GE HealthCare Technologies Inc.
GEHCQ2 2024(GEHC Q1 FY2024)Estimated3% AI
AI Revenue %
3%
AI Fair Value
$510.0M
AI Revenue (Q)
$139.5M
Total Revenue (Q)
$4.7B
Source: SEC EDGAR 10-Q Filing
View 10-Q on SEC.govAnalysis
Q1 2024 total revenue $4,650M (Products $3,045M + Services $1,605M). R&D increased to $324M (from $270M in Q1 2023), a 20% increase that management has attributed partly to AI/digital investments. The company launched CareIntellect in 2024, a cloud-based AI data platform. Risk factors continue to mention AI investment. No AI revenue is separately quantified. However, the growing AI algorithm portfolio (50+), launch of CareIntellect, and increasing premium on AI-enabled equipment justify a modest increase to 3%. This reflects AI software bundled in device sales, AI-enhanced service contract premiums, and early-stage CareIntellect subscription revenue. Math: ~$140M estimated AI / $4,650M total = ~3.0%.
Analyzed by claude-opus-4-6
Quoted Figures
Total revenues $4,650M (Q1 2024), Products $3,045M, Services $1,605M
10-Q 2024-03-31, Income Statement
Research and development $324M (Q1 2024) vs $270M (Q1 2023)
10-Q 2024-03-31, Income Statement
AI Products Identified (Ring 1)
Edison AI platformCareIntellect cloud AI platformCT Air Recon DLMR AIR Recon DLCommand CenterAI-enabled clinical applications
AI-Enabled Items (Ring 2 — Not Counted)
These items use AI but are not counted in the AI revenue estimate because they primarily serve non-AI functions.
Imaging segment equipmentAVS/Ultrasound devicesPCS monitoring systemsPDx contrast agentsService contracts
Confidence Tier
EstimatedNo direct AI revenue disclosure — estimated from product mix